RAYMOND COHEN
CO-FOUNDER/FORMER CEO
AXONICS
WHY: Co-founded Axonics, which makes sacral neuromodulation device to treat patients with overactive bladder conditions.
IN THE NEWS: Oversaw company’s $3.7B sale to Boston Scientific; deal closed in 2024. It was Cohen’s second successful sale of a medical device company to Boston Scientific.
NOTABLE: Named chairman of the board of Nalu Medical Inc. of Carlsbad in April 2025. Venture partner in two-funds—Andrea Partners of Paris and Sherpa Healthcare Partners of China. Also on board of Rxsight.
QUOTABLE: “We all want to be successful, but if you can do it by helping restore the quality of somebody’s life, what better endeavor could there be?”
